Breast and Cervical Cancer Early Detection and Control Advisory Committee (BCCEDCAC), 66469 [2012-26893]
Download as PDF
<![CDATA[
66469
Federal Register / Vol. 77, No. 214 / Monday, November 5, 2012 / Notices
DGMQ staff will search the literature
and available data sources to ensure that
the information of interest has not
already been collected or is in the
process of being collected. DGMQ will
make all reasonable efforts to ensure
that the information collection does not
overlap with other data collection on
immigrant health, such as those
authorized under OMB control numbers
1405–0113, 0920–0006, 1615–0029, and
1615–0033.
DGMQ staff proposes that data
collection methods for this package will
include but are not limited to:
Interviews, focus groups, group
discussions, and surveys. Depending on
the specific purpose, data collection
methods may be conducted either inperson, by telephone, on paper, or
online. Data may be collected in
quantitative and/or qualitative forms.
Each proposed information collection
will submit the tools used for data
collection, including screenshots of
web-based surveys, in the statement
provided to OMB.
DGMQ estimates that 18,720
respondents will be screened in order
for 9485 respondents to be involved in
information collection activities each
year. We anticipate that the information
collections undertaken within this
generic will use some combination of 15
surveys, 35 focus groups, and 125
interviews, with some information
collections making use of more than one
method per collection. It is estimated
that information collection activities
will total 10,598 burden hours per year.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Foreign-born, migrant,
bile populations.
Foreign-born, migrant,
bile populations.
Foreign-born, migrant,
bile populations.
Foreign-born, migrant,
bile populations.
refugee and other morefugee and other morefugee and other morefugee and other mo-
Dated: October 30, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science
(OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2012–26898 Filed 11–2–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Breast and Cervical Cancer Early
Detection and Control Advisory
Committee (BCCEDCAC)
WREIER-AVILES on DSK5TPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Name: Breast and Cervical Cancer Early
Detection and Control Advisory Committee.
Times and Dates: 9:00 a.m.–5:00 p.m.,
December 6, 2012; 9:00 a.m.–12:30 p.m.,
December 7, 2012.
Place: University Office Park, Columbia
Building, 2900 Woodcock Boulevard,
Atlanta, Georgia 30341.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
advising the Secretary, Department of Health
and Human Services, and the Director, CDC,
regarding the early detection and control of
VerDate Mar<15>2010
15:30 Nov 02, 2012
Number of
respondents
Form name
Jkt 229001
Number of
responses per
respondent
Average
burden per
response
(in hours)
Screeners for Surveys, Focus Groups, Interviews.
Surveys (Approximately 15 surveys/year) .....
18,720
1
10/60
9,000
1
45/60
Focus Groups (Approximately 35 focus
groups/year).
Interviews (Approximately 125 interviews/
year).
360
1
1.5
125
1
1.5
breast and cervical cancer. The committee
makes recommendations regarding national
program goals and objectives;
implementation strategies; and program
priorities including surveillance,
epidemiologic investigations, education and
training, information dissemination,
professional interactions and collaborations,
and policy.
Matters To Be Discussed: The agenda will
include discussion on the impact of
implementation of the Affordable Care Act
on the National Breast and Cervical Cancer
Early Detection Program; presentations on
outcomes of Care Coordination and Waiver
projects; and discussions on how to expand
services to impact women beyond our
eligible screening population.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Jameka R. Blackmon, Executive Secretary,
BCCEDCAC, Division of Cancer Prevention
and Control, National Center for Chronic
Disease Prevention and Health Promotion,
CDC, 4770 Buford Highway, Mailstop K–52,
Chamblee, Georgia 30314, Telephone: 770–
488–4880. The Director, Management
Analysis and Services Office, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Dated: October 26, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–26893 Filed 11–2–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
CDC/HRSA Advisory Committee on
HIV, Viral Hepatitis and STD Prevention
and Treatment
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) and the
Health Resources and Services
Administration (HRSA) announce the
following meeting of the
aforementioned committee:
Times and Dates:
8:00 a.m.–5:45 p.m., December 11, 2012
8:00 a.m.–2:30 p.m., December 12, 2012
Place: The Hilton Rockville, 1750
Rockville Pike, Rockville, Maryland
20852, Telephone: (301) 468–1100.
Status: Open to the public, limited
only by the space available. The meeting
room will accommodate approximately
100 people.
Purpose: This Committee is charged
with advising the Director, CDC and the
E:\FR\FM\05NON1.SGM
05NON1
]]>Agencies
[Federal Register Volume 77, Number 214 (Monday, November 5, 2012)]
[Notices]
[Page 66469]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-26893]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Breast and Cervical Cancer Early Detection and Control Advisory
Committee (BCCEDCAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Name: Breast and Cervical Cancer Early Detection and Control
Advisory Committee.
Times and Dates: 9:00 a.m.-5:00 p.m., December 6, 2012; 9:00
a.m.-12:30 p.m., December 7, 2012.
Place: University Office Park, Columbia Building, 2900 Woodcock
Boulevard, Atlanta, Georgia 30341.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with advising the Secretary,
Department of Health and Human Services, and the Director, CDC,
regarding the early detection and control of breast and cervical
cancer. The committee makes recommendations regarding national
program goals and objectives; implementation strategies; and program
priorities including surveillance, epidemiologic investigations,
education and training, information dissemination, professional
interactions and collaborations, and policy.
Matters To Be Discussed: The agenda will include discussion on
the impact of implementation of the Affordable Care Act on the
National Breast and Cervical Cancer Early Detection Program;
presentations on outcomes of Care Coordination and Waiver projects;
and discussions on how to expand services to impact women beyond our
eligible screening population.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Jameka R. Blackmon,
Executive Secretary, BCCEDCAC, Division of Cancer Prevention and
Control, National Center for Chronic Disease Prevention and Health
Promotion, CDC, 4770 Buford Highway, Mailstop K-52, Chamblee,
Georgia 30314, Telephone: 770-488-4880. The Director, Management
Analysis and Services Office, has been delegated the authority to
sign Federal Register notices pertaining to announcements of
meetings and other committee management activities, for both the
Centers for Disease Control and Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: October 26, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-26893 Filed 11-2-12; 8:45 am]
BILLING CODE 4163-18-P
